SGLT 2 INHIBITORS
Clinical trials for SGLT 2 INHIBITORS explained in plain language.
Never miss a new study
Get alerted when new SGLT 2 INHIBITORS trials appear
Sign up with your email to follow new studies for SGLT 2 INHIBITORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a diabetes drug shield kids' kidneys from protein damage?
Disease control OngoingThis study tests a drug called dapagliflozin (Forxiga) in 10 children aged 4-18 who have kidney disease and persistent protein in their urine despite standard treatment. The goal is to see if the drug can reduce protein leakage and protect kidney function. Participants take the d…
Matched conditions: SGLT 2 INHIBITORS
Phase: NA • Sponsor: Al-Quds University • Aim: Disease control
Last updated May 26, 2026 11:52 UTC
-
Diabetes drug eye risk under microscope
Knowledge-focused OngoingThis study looks at how newer diabetes medications (SGLT2 inhibitors and GLP-1 receptor agonists) affect the eyes of people with type 2 diabetes. Researchers will monitor 40 adults who take metformin and are starting these newer drugs. The goal is to see if these drugs cause any …
Matched conditions: SGLT 2 INHIBITORS
Sponsor: University of Athens • Aim: Knowledge-focused
Last updated May 26, 2026 11:55 UTC